Pharma Mar SA revenue for the last year amounted to 174.39 M USD, the most of which — 173.11 M USD — came from its highest performing source at the moment, Oncology, the year earlier bringing 204.61 M USD. The greatest contribution to the revenue figure was made by Ireland — last year it brought Pharma Mar SA 83.17 M USD, and the year before that — 92.88 M USD.